Evidence supporting see‐and‐treat management of cervical intraepithelial neoplasia: a systematic review and meta‐analysis
Background Studies of see‐and‐treat management of cervical intraepithelial neoplasia (CIN) vary in their inclusion criteria, resulting in a broad range of overtreatment rates. Objectives To determine overtreatment rates in see‐and‐treat management of women referred for colposcopy because of suspecte...
Gespeichert in:
Veröffentlicht in: | BJOG : an international journal of obstetrics and gynaecology 2016-01, Vol.123 (1), p.59-66 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Studies of see‐and‐treat management of cervical intraepithelial neoplasia (CIN) vary in their inclusion criteria, resulting in a broad range of overtreatment rates.
Objectives
To determine overtreatment rates in see‐and‐treat management of women referred for colposcopy because of suspected CIN, in order to define circumstances supporting see‐and‐treat management.
Search strategy
MEDLINE, EMBASE, and the Cochrane Library were searched from inception up to 12 May 2014.
Selection criteria
Studies of see‐and‐treat management in women with a reported cervical smear result, colposcopic impression, and histology result were included.
Data collection and analysis
Methodological quality was assessed with the Newcastle–Ottawa scale. We used the inverse variance method for pooling incidences, and a random‐effects model was used to account for heterogeneity between studies. Overtreatment was defined as treatment in patients with no CIN or CIN1.
Main results
Thirteen studies (n = 4611) were included. The overall overtreatment rate in women with a high‐grade cervical smear and a high‐grade colposcopic impression was 11.6% (95% CI 7.8–15.3%). The overtreatment rate in women with a high‐grade cervical smear and low‐grade colposcopic impression was 29.3% (95% CI 16.7–41.9%), and in the case of a low‐grade smear and high‐grade colposcopic impression it was 46.4% (95% CI 15.7–77.1%). In women with a low‐grade smear and low‐grade colposcopic impression, the overtreatment rate was 72.9% (95% CI 68.1–77.7%).
Author's conclusions
The pooled overtreatment rate in women with a high‐grade smear and high‐grade colposcopic impression is at least comparable with the two‐step procedure, which supports the use of see‐and‐treat management in this subgroup of women.
Tweetable
See‐and‐treat management is justified in the case of a high‐grade smear and a high‐grade colposcopic impression.
Tweetable
See‐and‐treat management is justified in the case of a high‐grade smear and a high‐grade colposcopic impression. |
---|---|
ISSN: | 1470-0328 1471-0528 |
DOI: | 10.1111/1471-0528.13530 |